Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,510 | -31,912 | -22,992 | -12,612 | -33,575 |
| Depreciation Amortization | 1,162 | 928 | 605 | 392 | 991 |
| Accounts receivable | -2,319 | -9,349 | -4,806 | -3,452 | -27 |
| Accounts payable and accrued liabilities | 62 | -4,033 | -5,535 | -6,222 | 6,182 |
| Other Working Capital | -7,626 | -13,764 | -11,430 | -8,149 | -547 |
| Other Operating Activity | 18,046 | 19,602 | 14,236 | 11,607 | 15,653 |
| Operating Cash Flow | $-38,185 | $-38,528 | $-29,922 | $-18,436 | $-11,323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -16 | -11 | N/A | -72 |
| Purchase Of Investment | -3,731 | -2,984 | -1,988 | -494 | -229,836 |
| Sale Of Investment | 3,980 | 2,486 | 1,490 | 996 | 288,287 |
| Purchase Sale Intangibles | -6,000 | -3,000 | -3,000 | -3,000 | -1,000 |
| Other Investing Activity | -6,000 | -3,000 | -3,000 | -3,000 | -1,094 |
| Investing Cash Flow | $-5,752 | $-3,514 | $-3,509 | $-2,498 | $57,285 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,500 | -3,500 | -2,332 | 0 | N/A |
| Common Stock Issued | 27,710 | 27,620 | 27,614 | 1,229 | 14,725 |
| Other Financing Activity | -739 | -566 | -356 | -78 | -93 |
| Financing Cash Flow | $23,471 | $23,554 | $24,926 | $1,151 | $14,632 |
| Exchange Rate Effect | 27 | 30 | 21 | 5 | -42 |
| Beginning Cash Position | 87,657 | 87,657 | 87,657 | 87,657 | 27,105 |
| End Cash Position | 67,218 | 69,199 | 79,173 | 67,879 | 87,657 |
| Net Cash Flow | $-20,439 | $-18,458 | $-8,484 | $-19,778 | $60,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,185 | -38,528 | -29,922 | -18,436 | -11,323 |
| Capital Expenditure | -1 | -16 | -11 | N/A | -72 |
| Free Cash Flow | -38,186 | -38,544 | -29,933 | -18,436 | -11,395 |